BioMed Central
Search results
Springer Nature advances discovery by publishing trusted research, supporting the development of new ideas and championing open science. We are committed to playing our part in accelerating solutions to address the world’s urgent challenges.
Springer Nature or the Springer Nature Group is a German-British academic publishing company created by the May 2015 merger of Springer Science+Business Media and Holtzbrinck Publishing Group's Nature Publishing Group, Palgrave Macmillan, and Macmillan Education.
Explore the leading weekly interdisciplinary science journal and discover Nature Portfolio journals which publish original research across the life, physical and clinical sciences. Our academic journals are prestigious titles in a broad range of specialties across 42 journals.
3 days ago · Nature publishes the finest peer-reviewed research that drives ground-breaking discovery, and is read by thought-leaders and decision-makers around the world. Skip to main content Thank you for...
SpringerLink is the reading platform of choice for hundreds of thousands of researchers worldwide. Find out how to publish your research with Springer Nature. Providing access to millions of research articles and chapters from Science, Technology and Medicine, and Humanities and Social Sciences.
The world’s most significant open access portfolio. We have published over 124,000 open access articles via Gold open access across disciplines –from the life sciences to the humanities, representing 33% of all Springer Nature articles in 2020.
180 years of progress - 180 years of discovery. We are a global and progressive business, founded on a heritage of trusted and respected brands – including Springer, founded in 1842, Macmillan, founded in 1843 and Nature, first published in 1869.
As a publishing technology business, we ensure that knowledge can be found, verified, understood and used, to help improve and enrich our lives and protect our planet for future generations. Curious to find out more? TAKING RESPONSIBILITY. Working together to solve the world’s biggest challenges.
Publish in Nature Communications: multidisciplinary, open access journal, with 16.6 Impact Factor, 10 days to first decision and 114M annual downloads. ... Springer Nature Ltd.
18 hours ago · The second quarter of 2024 picked up where Q1 left off, with a relatively muted 11 novel drug approvals (Table 1) to add to the tally of 10 approvals between January and March (Nat Rev. Drug Disc ...
